Boston Partners
- SEC CIK
- 0001386060
- Latest filing
- Aug 4, 2026
TAK holding history
Takeda Pharmaceutical Co Ltd in every 13F filed by Boston Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TAK overviewAll 13F holders of TAKFull Q2 2026 holdings
- Shares (Q2 2026)
- 84,903
- Value
- $1.36M
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 84,903 | $1.36M | <0.1% | −30,619−26.5% | Reduced | Holders |
| Q1 2026 | 115,522 | $2.14M | <0.1% | +21,812+23.3% | Added | Holders |
| Q4 2025 | 93,710 | $1.46M | <0.1% | −24,244−20.6% | Reduced | Holders |
| Q3 2025 | 117,954 | $1.73M | <0.1% | +12,219+11.6% | Added | Holders |
| Q2 2025 | 105,735 | $1.63M | <0.1% | −26,372−20.0% | Reduced | Holders |
| Q1 2025 | 132,107 | $1.96M | <0.1% | +63,024+91.2% | Added | Holders |
| Q4 2024 | 69,083 | $914.7K | <0.1% | +69,083 | New | Holders |